Return to homepagePandemic Pact

Production of SARS-CoV-2 antigenic recombinant proteins

  • Funded by Agence Universitaire de la Francophonie (AUF)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2020

  • Known Financial Commitments (USD)

    $0

  • Funder

    Agence Universitaire de la Francophonie (AUF)

  • Principal Investigator

    N/A

  • Research Location

    Viet Nam

  • Lead Research Institution

    Université nationale du Vietnam à Hô Chi Minh-Ville

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Project summary SARS-CoV-2 is the source of the COVID-19 pandemic. Serological tests are needed to detect antibodies specific to the virus. This project aims to help local laboratories and businesses develop rapid, reliable and inexpensive COVID-19 screening tests using recombinant protein technology. Goals Target different domains of S-spike protein that play important roles in the immune response and in inducing neutralizing antibody responses. Produce them using recombinant protein technology, then assess their quality and ability to bind to specific antibodies and the human ACE2 receptor. Contribute to studies on COVID-19 in Vietnam and transfer the protocol and bacterial strains to biotechnology units wishing to develop screening kits.